- Home
- TNGX vs CMPS Comparison
TNGX vs CMPS Comparison
Compare TNGX & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CMPS
- Stock Information
- Founded
- TNGX 2014
- CMPS 2020
- Country
- TNGX United States
- CMPS United Kingdom
- Employees
- TNGX N/A
- CMPS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- TNGX Health Care
- CMPS Health Care
- Exchange
- TNGX Nasdaq
- CMPS Nasdaq
- Market Cap
- TNGX 413.6M
- CMPS 362.6M
- IPO Year
- TNGX N/A
- CMPS 2020
- Fundamental
- Price
- TNGX $3.92
- CMPS $4.41
- Analyst Decision
- TNGX Strong Buy
- CMPS Strong Buy
- Analyst Count
- TNGX 8
- CMPS 7
- Target Price
- TNGX $13.14
- CMPS $30.67
- AVG Volume (30 Days)
- TNGX 3.5M
- CMPS 1.5M
- Earning Date
- TNGX 11-06-2024
- CMPS 10-31-2024
- Dividend Yield
- TNGX N/A
- CMPS N/A
- EPS Growth
- TNGX N/A
- CMPS N/A
- EPS
- TNGX N/A
- CMPS N/A
- Revenue
- TNGX $43,383,000.00
- CMPS N/A
- Revenue This Year
- TNGX $25.55
- CMPS N/A
- Revenue Next Year
- TNGX N/A
- CMPS N/A
- P/E Ratio
- TNGX N/A
- CMPS N/A
- Revenue Growth
- TNGX 15.67
- CMPS N/A
- 52 Week Low
- TNGX $2.70
- CMPS $4.05
- 52 Week High
- TNGX $13.01
- CMPS $12.75
- Technical
- Relative Strength Index (RSI)
- TNGX 39.26
- CMPS 31.94
- Support Level
- TNGX $3.54
- CMPS $4.47
- Resistance Level
- TNGX $4.22
- CMPS $4.88
- Average True Range (ATR)
- TNGX 0.53
- CMPS 0.45
- MACD
- TNGX 0.13
- CMPS -0.03
- Stochastic Oscillator
- TNGX 48.61
- CMPS 11.89
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.